Skip to main content
. 2004 May 11;90(11):2232–2242. doi: 10.1038/sj.bjc.6601862

Figure 4.

Figure 4

Reversed-phase high-performance liquid chromatograms of [18F]FETA and its putative metabolites at an early time-point (10 min p.i.) in plasma (A), liver (D), and tumour (G), and a late time-point (60 min p.i.) in plasma (B), muscle (C), liver (E), gall bladder (F), tumour (H), and urine (I). Filled arrows are parent [18F]FETA compound, and double-lined arrows are metabolites.